Cilgavimab 150 mg in 1.5 mL, tixagevimab 150 mg in 1.5 mL, 2 vial carton (EUA)
RxNorm 2587312

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2587312 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: cilgavimab 150 mg in 1.5 mL, tixagevimab 150 mg in 1.5 mL, 2 vial carton (EUA).

The following semantic concepts and normalized strings are associated with this clinical entity:

PSN
Cilgavimab 150 mg in 1.5 mL, tixagevimab 150 mg in 1.5 mL, 2 vial carton (EUA)
AUI:12721241
View
SY
Cilgavimab 150 mg per 1.5 mL, tixagevimab 150 mg per 1.5 mL, 2 vial carton (EUA)
AUI:12716309
View
GPCK
{1 (1.5 mL cilgavimab 100 mg/ML Injection) / 1 (1.5 mL tixagevimab 100 mg/ML Injection) } Pack
AUI:12716303
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

PSN

Prescribable Name (PSN):
Cilgavimab 150 mg in 1.5 mL, tixagevimab 150 mg in 1.5 mL, 2 vial carton (EUA)
(Atom ID: 12721241)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
cilgavimab 150 MG in 1.5 ML, tixagevimab 150 MG in 1.5 ML, 2 vial carton (EUA)
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2587312
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12721241
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
2587312
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SY

Synonym (SY):
Cilgavimab 150 mg per 1.5 mL, tixagevimab 150 mg per 1.5 mL, 2 vial carton (EUA)
(Atom ID: 12716309)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
cilgavimab 150 MG per 1.5 ML, tixagevimab 150 MG per 1.5 ML, 2 vial carton (EUA)
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2587312
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12716309
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
2587312
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
GPCK

Generic Pack (GPCK):
{1 (1.5 mL cilgavimab 100 mg/ML Injection) / 1 (1.5 mL tixagevimab 100 mg/ML Injection) } Pack
(Atom ID: 12716303)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
{1 (1.5 ML cilgavimab 100 MG/ML Injection) / 1 (1.5 ML tixagevimab 100 MG/ML Injection) } Pack
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2587312
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12716303
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
GPCK
Generic Pack ({# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack)
Source Code
2587312
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN OBSOLETED
01/27/2026
Date the RxNorm atom became obsolete